Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...

Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins ...

Endomyocardial biopsy is the only method by which the presence of cardiac amyloidosis can be directly established in cardiac amyloidosis, but this method is invasive, expensive and not always ...

Amyloid cardiomyopathy (cardiac amyloidosis) is a form of restrictive cardiomyopathy that can result in significant progressive diastolic congestive heart failure. As the name suggests ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...

Findings from this collaboration have the potential to impact not only amyloidosis but also other cardiac conditions, where non-invasive, information-rich diagnosis and monitoring are crucial.

The trial is designed to determine the sensitivity and specificity of 124 I-evuzamitide imaging to diagnose cardiac amyloidosis. “This study seeks to add significant value for patient care ...

a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic amyloidosis, and Brigham and Women's Hospital, Boston, MA, are pleased to ...